RxDoctor Payments Data

Michael Cooperman

Internal Medicine · Melrose Park, PANPI 1972568244

Payments from drug & device makers

$41,607in general payments, 2019–2025

Across 454 payments — averaging $91.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$34K
  • Johnson & Johnson$2K
  • Lilly USA, LLC$1K
  • Sanofi-aventis U.S. LLC$967
  • AstraZeneca$555
  • Novo Nordisk$515
  • plus $2K from 12 others

What the payments were for

  • Speaking & faculty fees$32,19080%
  • Travel & lodging$2,0095%
  • Food & beverage$6,15015%
  • Education$200%
  • Gifts$590%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,607 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.

See all internal medicine providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp14$3,845

Paid to pharmacies, not to this prescriber.

Other internal medicine in Melrose Park

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →